Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Redekop

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Orphanet Journal of Rare Diseases|August 17, 2013
Systematic review of available evidence on 11 high-priced inpatient orphan drugsTim A Kanters, Caroline de Sonneville-Koedoot, W Ken Redekop, et al.
European Radiology|June 10, 2026
Evaluation of standardized DICOM labels assigned by a hybrid AI tool and its impact on radiologists' reading timesBina Tariq, Meike W Vernooij, Ken Redekop, et al.
Journal of Medical Internet Research|October 11, 2021
Mobile Safety Alarms Based on GPS Technology in the Care of Older Adults: Systematic Review of Evidence Based on a General Evidence Framework for Digital Health TechnologiesMaria Ehn, Matt X Richardson, Sara Landerdahl Stridsberg, et al.
BMC Health Services Research|June 30, 2021
Nocturnal digital surveillance in aged populations and its effects on health, welfare and social care provision: a systematic reviewMatt X Richardson, Maria Ehn, Sara Landerdahl Stridsberg, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 15, 2015
Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug?Tim A Kanters, Leona Hakkaart, Maureen Pmh Rutten-van Mölken, et al.
JAMA Network Open|August 26, 2020
Cost-effectiveness of Mechanical Thrombectomy More Than 6 Hours After Symptom Onset Among Patients With Acute Ischemic StrokeAnne-Claire Peultier, Ankur Pandya, Richa Sharma, et al.
Journal of Medical Internet Research|March 23, 2022
Gray Literature in Evaluating Effectiveness in Digital Health and Health and Welfare Technology: A Source Worth ConsideringSara Landerdahl Stridsberg, Matt X Richardson, Ken Redekop, et al.
Journal of Evaluation in Clinical Practice|December 21, 2005
Measuring the perceived impact of facilitation on implementing recommendations from external assessment: lessons from the Dutch visitatie programme for medical specialistsM J M H Kiki Lombarts, N S Niek Klazinga, K Ken Redekop
Pharmacoeconomics|September 17, 2008
Costs and effects of secondary prevention with perindopril in stable coronary heart disease in Poland: an analysis of the EUROPA study including 1251 Polish patientsW Ken Redekop, Ewa Orlewska, Pawel Maciejewski, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 23, 2012
Explaining length of stay variation of episodes of care in the NetherlandsSiok Swan Tan, Leona Hakkaart-van Roijen, B Martin van Ineveld, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Orphanet Journal of Rare Diseases|August 17, 2013
Systematic review of available evidence on 11 high-priced inpatient orphan drugsTim A Kanters, Caroline de Sonneville-Koedoot, W Ken Redekop, et al.
European Radiology|June 10, 2026
Evaluation of standardized DICOM labels assigned by a hybrid AI tool and its impact on radiologists' reading timesBina Tariq, Meike W Vernooij, Ken Redekop, et al.
Journal of Medical Internet Research|October 11, 2021
Mobile Safety Alarms Based on GPS Technology in the Care of Older Adults: Systematic Review of Evidence Based on a General Evidence Framework for Digital Health TechnologiesMaria Ehn, Matt X Richardson, Sara Landerdahl Stridsberg, et al.
BMC Health Services Research|June 30, 2021
Nocturnal digital surveillance in aged populations and its effects on health, welfare and social care provision: a systematic reviewMatt X Richardson, Maria Ehn, Sara Landerdahl Stridsberg, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 15, 2015
Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug?Tim A Kanters, Leona Hakkaart, Maureen Pmh Rutten-van Mölken, et al.
JAMA Network Open|August 26, 2020
Cost-effectiveness of Mechanical Thrombectomy More Than 6 Hours After Symptom Onset Among Patients With Acute Ischemic StrokeAnne-Claire Peultier, Ankur Pandya, Richa Sharma, et al.
Journal of Medical Internet Research|March 23, 2022
Gray Literature in Evaluating Effectiveness in Digital Health and Health and Welfare Technology: A Source Worth ConsideringSara Landerdahl Stridsberg, Matt X Richardson, Ken Redekop, et al.
Journal of Evaluation in Clinical Practice|December 21, 2005
Measuring the perceived impact of facilitation on implementing recommendations from external assessment: lessons from the Dutch visitatie programme for medical specialistsM J M H Kiki Lombarts, N S Niek Klazinga, K Ken Redekop
Pharmacoeconomics|September 17, 2008
Costs and effects of secondary prevention with perindopril in stable coronary heart disease in Poland: an analysis of the EUROPA study including 1251 Polish patientsW Ken Redekop, Ewa Orlewska, Pawel Maciejewski, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 23, 2012
Explaining length of stay variation of episodes of care in the NetherlandsSiok Swan Tan, Leona Hakkaart-van Roijen, B Martin van Ineveld, et al.
Pageof 9